Healthcare / Medical Care FacilitiesNYSE
$144.69
-1.42 (-0.97%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $824.5M · quality 53.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$8.8B
P/E
6.0x
↓EV/EBITDA
5.2x
↓ROE
20.5%
↑Gross Margin
90.4%
↑Debt/Equity
0.71
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
+11.0%
FCF margin
4.7%
FCF / Net income
0.55x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $17.36B · net income $1.49B · FCF $824.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $17.36B | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | $7.37B | $6.96B | $6.76B | $4.90B | — | — |
| Net Income | $1.49B | $1.49B | $1.14B | $717.8M | $675.6M | $991.6M | $944.0M | $814.9M | $779.7M | $752.3M | $702.4M | $680.5M | $545.3M | $510.7M | $443.4M | $398.2M | $230.2M | $260.4M | $199.4M |
| EBITDA | $2.74B | $2.74B | $2.27B | $1.72B | $1.58B | $1.90B | $1.87B | $1.71B | $1.63B | $1.73B | $1.70B | $1.66B | $1.44B | $1.35B | $1.25B | $1.19B | $729.7M | $725.2M | $606.0M |
| EPS | 23.10 | 23.10 | 16.82 | 10.23 | 9.14 | 11.82 | 10.99 | 9.13 | 8.31 | 7.81 | 7.14 | 6.76 | 5.42 | 5.14 | 4.53 | 4.04 | 2.34 | 2.64 | 1.96 |
| Gross Margin | 90.4% | 90.4% | 90.0% | 89.3% | 89.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 11.5% | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 13.9% | 13.0% | 13.8% | 13.5% | 13.3% | 10.3% | — | — |
| Net Margin | 8.6% | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% | 7.5% | 6.6% | 6.9% | 6.4% | 5.9% | 4.7% | — | — |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | 0.71 | 0.71 | 0.74 | 0.87 | 0.89 | 0.68 | 0.56 | 0.71 | 0.73 | 0.70 | 0.89 | 0.79 | 0.86 | 0.99 | 1.37 | 1.59 | 1.98 | 0.55 | — |
| Current Ratio | 1.08 | 1.08 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $824.5M | $824.5M | $1.12B | $524.7M | $262.0M | $28.0M | $1.63B | $804.4M | $609.8M | $690.1M | $813.9M | $688.9M | $644.7M | $525.7M | $436.0M | $425.0M | $262.1M | $161.5M | $139.7M |
| Returns | |||||||||||||||||||
| ROE | 20.5% | 20.5% | 17.1% | 11.7% | 11.4% | 16.3% | 14.9% | 14.8% | 14.5% | 15.1% | 15.5% | 16.0% | 14.6% | 15.7% | 16.3% | 17.3% | 11.6% | 14.9% | — |
| Valuation | |||||||||||||||||||
| P/E | 6.04 | 6.04 | 10.64 | 15.02 | 16.63 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 5.23 | 5.23 | 7.49 | 9.34 | 10.40 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.28 | 1.28 | 1.82 | 1.75 | 1.90 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 9.7% | 9.7% | 10.8% | 6.6% | — | 9.4% | 1.6% | 5.6% | 3.5% | 6.6% | 8.0% | 10.2% | 11.4% | 5.8% | 3.0% | 38.0% | — | — | — |
| EPS Growth | 37.3% | 37.3% | 64.4% | 11.9% | — | 7.6% | 20.4% | 9.9% | 6.4% | 9.4% | 5.6% | 24.7% | 5.4% | 13.5% | 12.1% | 72.6% | -11.4% | 34.7% | — |
| Dividend Yield | 0.5% | 0.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-17.8%
EPS terminal req.
$12.84
Spread vs growth
55.1%
5Y implied EPS CAGR
-7.6%
EPS terminal req.
$15.53
Spread vs growth
45.0%
10Y implied EPS CAGR
0.8%
EPS terminal req.
$25.02
Spread vs growth
36.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.4%
Start / end P/E
11.3x → 6.3x
EPS bridge
16.82 → 23.10
Residual
-16.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.